RITTER PHARMACEUTICALS INC 4
4 · RITTER PHARMACEUTICALS INC · Filed Jun 30, 2015
Insider Transaction Report
Form 4
Ritter Ira E.
DirectorExec. Chairman, CSO
Transactions
- Conversion
Common Stock
2015-06-29+817,272→ 817,272 total(indirect: By LLC) - Conversion
Convertible Preferred Stock
2015-06-29−817,272→ 0 total(indirect: By LLC)→ Common Stock (817,272 underlying)
Footnotes (2)
- [F1]Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Stonehenge Partners LLC converted into Common Stock of the issuer on a one-for-one basis and had no expiration date.
- [F2]As a managing partner of Stonehenge Partners LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.